The ASXL genes (ASXL1, ASXL2, and ASXL3) participate in body patterning during embryogenesis and encode proteins involved in epigenetic regulation and assembly of transcription factors to specific genomic loci. Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features. ASXL2 has not yet been associated with a human Mendelian disorder. In this study, we performed whole-exome sequencing in six unrelated probands with developmental delay, macrocephaly, and dysmorphic features. All six had de novo truncating variants in ASXL2. A careful review enabled the recognition of a specific phenotype consisting of macrocephaly, prominent eyes, arched eyebrows, hypertelorism, a glabellar nevus flammeus, neonatal feeding difficulties, hypotonia, and developmental disabilities. Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1-and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities. We were also able to demonstrate with mRNA studies that these variants are likely to exert a dominant-negative effect, given that both alleles are expressed in blood and the mutated ASXL2 transcripts escape nonsense-mediated decay. In conclusion, de novo truncating variants in ASXL2 underlie a neurodevelopmental syndrome with a clinically recognizable phenotype. This report expands the germline disorders that are linked to the ASXL genes.
function, and vertebral abnormalities, indicating that this gene is required for embryonic and postnatal development. 5 Germline mutations in ASXL1 and ASXL3 have been associated with specific genetic syndromes. 10 Truncating variants in ASXL1 cause Bohring-Opitz syndrome (MIM: 605039), a severe disorder with growth retardation, microcephaly, profound intellectual disability, nevus flammeus of the face, flexion of the elbows and wrists, and ulnar deviation of the hands. 11, 12 ASXL3 germline truncating variants are associated with Bainbridge-Ropers syndrome (MIM: 615485), characterized by severe intellectual disability, growth retardation, and clinical features overlapping those of Bohring-Opitz syndrome. 13 Variants in ASXL3 have also been reported in autism spectrum disorder. 14 In contrast, ASXL2 (MIM: 612991) has thus far not been implicated in human Mendelian disease. One individual with a t(2;9) translocation resulting in a fused transcript of ASXL2 and KIAA1803 had a complex phenotype of agenesis of the corpus callosum, ocular colobomas, and periventricular heterotopias, 15 but the relative contributions of the two genes to this individual's phenotype are unclear. Similarly, DECIPHER lists five individuals with cytogenetic deletions encompassing ASXL2 and other genes (n ¼ 35-141) and phenotypes including developmental delays or intellectual disabilities, among other manifestations (Table S1 ). Because of the contiguous deletion of several other genes, the specific contribution of the ASXL2 deletion to these phenotypes cannot be determined. Also included is an individual with a single de novo base-pair deletion causing head, neck, nervous, skeletal, skin, and respiratory system abnormalities, and potential overlapping manifestations are detailed in our individuals.
In this study, we present six unrelated individuals ranging from 11 months to 31 years of age with de novo heterozygous truncating ASXL2 variants detected by whole-exome sequencing (WES). All individuals share overlapping clinical features including developmental or intellectual impairments, macrocephaly, distinct facial dysmorphisms, facial nevus flammeus, feeding difficulties in the newborn period, and hypotonia (Table 1 and Figure 1 ). Detailed clinical summaries are available in the Supplemental Note. Five of the individuals (individuals 1-3, 5, and 6) and their biological parents underwent trio WES, whereas individual 4 was sequenced alone, followed by Sanger sequencing of ASXL2 on the child and the biological parents. WES was performed after written informed consent was obtained through approval by institutional review boards and ethics committees. Experienced pediatricians and geneticists clinically assessed the individuals.
For all six individuals, DNA was extracted from maternal, paternal, and proband blood samples. The exome was captured with biotin-labeled VCRome 2.1 in-solution exome probes (individuals 1 and 4), the Agilent Clinical Research Exome Kit (individual 2), the Nextera Rapid Capture Exome Kit (individuals 3 and 6), or Agilent SureSelect v. 4 (individual 5) , and the exomes were sequenced on an Illumina HiSeq 2000 (individuals 2 and 5) or 2500 (individuals 1, 3, 4, and 6). Two paired-end 100 bp reads were used for the exome-capture sequencing. For individual 3, Trimmomatic 16 was employed to remove adapters and lowquality (Phred quality score < 5) bases from the 3 0 ends of sequence reads. Reads shorter than 36 bp were subsequently removed. The sequencing methodology, further processing, and variant-interpretation protocols have been described previously. [17] [18] [19] 20, 21 Table S2 . GeneMatcher, a web-based tool for researchers and clinicians working on identical genes, connected the investigators from the different institutions.
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Processing of the whole-exome data on the six unrelated individuals with overlapping clinical features ( Figure 1 and Table 1 ) and the healthy parents of five of them took into account X-linked, autosomal-recessive, and autosomaldominant inheritance models to identify genes with functionally relevant variants (new, clinically associated, or of low or unknown frequency) (Table S3 ). In the five trios, we identified one to two putatively de novo variants not present in any variant database (Table S3) . De novo variants (frameshift and stop gain) in ASXL2 were detected among all individuals (Table 1) . All ASXL2 variants were validated by Sanger sequencing, and the de novo origin was confirmed by parental-segregation studies ( Figure S2A ). Interestingly, all identified variants locate to the penultimate or last exon of ASXL2 (Figure 2 Figure 2 ). The annotation of these LoF variants in the ExAC Browser prompted us to calculate the probability of finding ASXL2 variants by chance in exomes for neurodevelopmental The American Journal of Human Genetics 99, 1-9, October 6, 2016 3 23 package with the parameters set for six truncating variants in ASXL2 and estimated that the probability of the chance occurrence of the six de novo ASXL2 mutations among 12,030 individuals is 1.47eÀ10. Correcting for the 18,668 protein-coding genes present in the consensus coding sequence (CCDS release 14) shows that this observation is significant genomewide (2.744196eÀ6). Conversely, for the probability of finding six ASXL2 truncating variants in the ExAC Browser (60,000 samples), we found a p value of 1.79eÀ6, which translates to 0.03341572 when corrected for 18,668 genes. These data indicate that there are fewer than expected truncating ASXL2 variants within the control database as well. ASXL2 is also highly intolerant of LoF variants (probability of 0.99) according to the ExAC Browser pLI calculation. 24 The ExAC Browser endeavors not to include subjects with severe pediatric disease but is enriched with adults with heart and metabolic diseases, cancer, schizophrenia, and Tourette syndrome. 24 Interestingly, truncating variants in ExAC Browser control individuals have been reported for both ASXL1 and ASXL3; these overlap the disease-associated variants occurring within the last two exons of both genes. 13, 25 Similarly, other genes involved in intellectual disability, such as ARID1B, have also been found to have truncating variants in ExAC Browser control individuals. 25 The exact explanation for these ExAC Browser variants that overlap the disease-associated variants for the three ASXL genes remains unclear, but possibilities include somatic mosaicism, variable expressivity depending on the location of the variants in the gene, or reduced penetrance. The finding that clonal hematopoiesis in healthy subjects results in acquired somatic variants in genes (including ASXL1) that are also mutated in myeloid cancers supports the possibility that the variants in the ExAC Browser could be somatic rather than germline. 24 Options such as examining read counts to determine whether a variant could be postzygotic are subject to errors due to sequencing factors such as variability in capture, and so at this time, definite inferences cannot be made about the origin of these variants. Nonpenetrance would be a less likely explanation, given the severity of the germline ASXL disorders, but a recent report has confirmed that incomplete penetrance of Mendelian diseases is likely to be more common than realized. 26 Future studies on all three ASXL genes are necessary for better understanding the overlap between truncating variants in control and affected individuals.
As for ASXL1 and ASXL3, we initially postulated that haploinsufficiency would be responsible for the ASXL2 phenotype; alternatively, a dominant-negative mechanism could cause disease. When truncating variants preferentially accumulate toward the end of a gene, the resulting transcript could escape nonsense-mediated decay (NMD) and interfere with the wild-type protein, causing an abnormal phenotype. The truncating variants in our six affected individuals are within the last two exons of ASXL2, similar to the distribution of disease-causing variants in ASXL1 and ASXL3. 11, 13, 25 To get an idea of whether haploinsufficiency or a dominant-negative effect could be the underlying mechanism of disease, we performed cDNA studies. We found that both wild-type and mutant transcripts were detectable at equal levels in all investigated individuals ( Figure S2B ). This suggests that at least for the three analyzed ASXL2 mutations, the mRNA containing the respective mutations is unlikely to undergo NMD, thus providing support for a dominant-negative rather than haploinsufficient mechanism of disease. Similarly, the disease mechanism with ASXL1 and ASXL3 needs further clarification. Bainbridge et al. demonstrated that in a cell line of an individual with an ASXL3 truncating variant, both alleles were expressed, suggesting that the truncating variant escaped NMD. 13 In contrast, others have demonstrated that transcripts from truncating variants in ASXL3 were indeed subject to NMD, making a dominant-negative effect less likely. Nonetheless, because NMD is a variable process depending on the tissue and time in development, this remains a possibility in ASXL-related disorders. Figure S1 ), as well as developmental delays (HP: 0001263) and intellectual disabilities (HP: 0001249) ranging from low average cognition to severe impairments, are also consistently seen. Less consistent features include multiple capillary malformations and skeletal findings. Persistent hypoglycemia occurred in individuals 2 and 3. The cause of hypoglycemia in both cases is not clear, but the observation of macrosomia at birth and variably in later life, the inappropriately low free fatty acids and ketones, and the high insulin concentration in Figure 2 . Schematic Structure of ASXL2 The ASXN, ASXM, and PHD-type zincfinger domains, which are conserved throughout the ASXL family, are represented as light-gray boxes, and the LVTQLL motif, a nuclear receptor binding motif, is indicated in dark gray. The amino acid (AA) positions of all domains and motifs, as well as a schematic representation of the exons encoding the above depicted part of the protein, are given underneath. The positions of the de novo mutations identified in this study are marked with vertical red arrows. Small green arrows point to positions of known heterozygous variants (stop gain, frameshift, and splice site) found in apparently healthy individuals (from the ExAC Browser). individual 3 on one occasion all suggest that an impaired regulation of insulin production or a disturbed peripheral effect on adipose tissue cells could play a role.
Germline damaging variants in ASXL1 and ASXL3 cause Bohring-Opitz and Bainbridge-Ropers syndromes, respectively. 11, 13 Overlapping features between our individuals and those with these disorders include developmental delays, arched eyebrows, feeding difficulties, and prominent eyes. A glabellar nevus flammeus is a striking feature in our six individuals and is seen in the majority of individuals with Bohring-Opitz syndrome, but not in BainbridgeRopers syndrome. Features that distinguish our individuals from those with these disorders include macrocephaly, normal height and weight, the absence of a characteristic positioning of the hands, and more variability in the degree of cognitive impairments. The overlap between the manifestations in the three different disorders could be due to the similarities in function between the members of the ASXL family of genes. Conversely, the distinctive features of the ASXL2-associated disorder could be attributed to the differences between the function of ASXL2 and those of the other two ASXL genes. 8 Overall, the presence of a glabellar nevus flammeus with developmental disabilities should prompt consideration of an ASXL-related disorder. ASXL proteins function as tumor suppressors or oncogenes, and truncating somatic variants of all three ASXL genes are found in many malignancies. 3, 29 Interestingly, Wilms tumor and nephroblastomatosis have been described in individuals with Bohring-Opitz syndrome. 30, 31 Thus, surveillance for Wilms tumor has been recommended for individuals with Bohring-Opitz syndrome. 30 It is unknown at this time whether germline damaging variants in ASXL2 would confer a risk of cancer; although none of our individuals has had a malignancy, follow-up clinical surveillance would be important. In Asxl2 À/À mice, fetuses have reduced body weight, skeletal anomalies, and cardiac dysfunction with enlarged hearts and premature death. 5 ASXL2 is also ubiquitously expressed in the brain of mouse embryos 5 and is reported to regulate bone mineral density and be responsible for the genesis of osteoclasts, as well as for bone resorption. 6, 32 Asxl2 À/À mice have been variably reported as having decreased bone density or osteopetrotic bone. Interestingly, individual 1 in our series has been noted to have increased alveolar bone density, a highly unusual dental finding. Individual 4 has decreased bone density with fractures, and individual 6 has mild osteoporosis. It is unclear at this point whether mineralization could be abnormal in other individuals with this ASXL2-related disorder; more clarity on this should become available with more reports of individuals with ASXL2 truncating variants. ASXL2 plays an important role in heart morphogenesis and the transition from fetal to postnatal circulation. 33 
Asxl2
À/À mice display congenital heart malformations including a thickened compact myocardium in the left ventricle, membranous ventricular septal defects, and dilated cardiomyopathy. 5 Four of the six individuals in our report have minor congenital heart disease, suggesting that cardiac malformations could be common in this condition.
In conclusion, we have identified a syndrome characterized by developmental disabilities, macrocephaly, and dysmorphic features attributable to germline truncating variants in ASXL2. Further clinical reports of individuals with damaging ASXL2 variants and related clinical features, as well as functional investigations, will reveal the full phenotype of this syndrome.
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Supplemental Note: Case Reports
Individual 1: An 8.5 year-old male of African-American, American-Indian and Caucasian origin had been evaluated on three occasions starting at 3.5 years, due to macrosomia, macrocephaly, dysmorphic features and mild developmental delays. At age 8 years he was enrolled into the Undiagnosed Diseases Network for further diagnostic evaluations.
He was born at 35 weeks' gestation to a 33 year-old, G 5 P 2 SAB 2 mother and a 49 year-old father, after an uncomplicated pregnancy. Birth weight was 3.9 kg (Z=3.28), length was 52.1 cm (Z=2.45) and occipitofrontal circumference (OFC) was 34 cm (Z=1.39). A large nevus flammeus in the glabellar region was noted.
He walked at 18 months and spoke his first words at 2 years of age. At 6 years, a diagnosis of Pervasive Developmental Disorder was made. At 8.5 years, the Wechsler Intelligence Scale for Children-Fifth Edition showed functioning in the borderline to low average range, with similar academic scores. Attention problems, aggressive behavior and conduct problems were identified.
He has had three febrile seizures. At age 3.3 years, the radiographic bone age was 5 years (>2SD). An ophthalmological examination showed mild proptosis, external rotation of the orbits and ovoid shaped corneas. On examination at age 8.5 years, height was 158.8 cm (Z= 4.39), weight was 67.2 kg (Z= 3.23) and OFC was 60 cm (Z=5.23). Dysmorphic features are noted in Table 1 and Figure 1A and B. The palate was high-arched.
Multiple capillary malformations were noted throughout his body, ranging from 0.4 cm to 2.8 cm ( Figure 1C ).
Deep palmar creases and generalized hypotonia were noted.
Individual 2:
A 10 month-old boy of Caucasian origin had been evaluated on three occasions, due to dysmorphic features, hypoglycemia and developmental delay.
He
cm (Z=5.63) and OFC was 37 cm (Z=2.41). An echocardiogram showed an ASD and decreased left ventricular function and he required ventilator assistance for four days. Persistent hypoglycemia and feeding difficulties necessitated nasogastric feeds. A large glabellar nevus flammeus, capillary malformations on the neck and hypotonia were noted.
Persistent feeding difficulties resulted in the placement of a gastric tube at age 3 months. He receives continuous feedings due to persistent hypoglycemia of unknown cause, with normal insulin and pituitary hormones. Cardiac function has normalized, but the ASD is still present. A brain MRI showed prominent extraaxial spaces and a choroid plexus papilloma in the right ventricle ( Figure S1 ).
Developmental milestones have been delayed. At nine months of age he could track, reach for objects, roll over, sit with support and was cooing.
On review of the family history, the mother has hypertelorism and recurrent hypoglycemia, but is of normal intellect. The father has mild hypertrophic cardiomyopathy and a cardiomyopathy gene panel is pending.
Parental head circumferences are not available. On examination at four months, his weight was 7.3 kg (Z=0.29), length was 66.5 cm (Z=0.86) and OFC was 43.5 cm (Z=1.08). At 7 months, the OFC was 46.2 cm (Z=1.8). Multiple dysmorphic features detailed in Table   1 and Figure 1D -F were noted, along with deep palmar creases and hypotonia.
Individual 3: A 4 year 7 month old Caucasian female was evaluated several times due to macrocephaly, dysmorphic features, ASD, developmental delays, seizures and hypotonia.
She was born after an uneventful pregnancy at 40+2 weeks to a 32 year-old G 1 P 1 mother and a 37 year-old father, with a birth weight of 3.3 kg (Z=-0.29), a birth length of 53 cm (Z=2.07), and an OFC of 35.5 cm (Z=1.37). Neonatal hypotonia and feeding difficulties were noted but resolved spontaneously. Soon after birth an echocardiogram showed a large ASD, which got smaller but is still present at the age of 4.5 years.
She rolled over at 6 months, crawled at 3 years, sat at 3 years 7 months and walked with support at 4 years 7 months. At the age of 4 years she had no spoken words. Hearing has been tested repeatedly, with inconclusive results. Horizontal nystagmus, noticed at 6 months, resolved after treatment with occlusion therapy and vision has been normal. First teeth erupted at 14 months and the first deciduous teeth were lost at 4 years.
At one year of age, she had a febrile seizure, followed by rare non-febrile generalized seizures and more frequent absence seizures, which have responded well to sulthiame. Scoliosis was diagnosed at 12 months and is treated by corset. At age 2.5 years she had episodes of early morning hypoglycemia (blood glucose of 41 mg/dl). Pituitary hormones were normal; insulin level was inappropriately high, with low free fatty acids and ketones on one occasion. Eating regularly and avoiding long fasting periods resolved this. The family history is unremarkable. Parental OFCs were within normal limits.
Chromosomal microarray (NimbleGen 135K), 7-dehydrocholesterol and testing of select exons of FGFR2 and FGFR3, TWIST1 and PTPN11 sequencing were all normal.
On examination at 4 years 1 month, the patient's weight was 16.4 kg (Z=-0.05), length 99.2 cm (Z =-0.91), OFC 54.8 cm (Z=3.2). Dysmorphic features included shallow orbital ridges with proptosis, upturned nose, posteriorly rotated ears, high-arched palate, and micrognathia with small mouth (Table 1 and Fig. 1J -L).
Individual 5: This 10 year-old Caucasian male had been evaluated several times since 5 years of age due to developmental delay. He was born at 37 weeks' gestation to a 34 year-old mother and a 38 year-old father.
Birth weight was 2140 g (Z=-2.15) and length was 48 cm (Z=-0.74). He had a glabellar nevus flammeus and feeding difficulties.
He walked at the age of 19.5 months and spoke his first words after 2 1/2 years. At the age of 6 years, 9 months, his full-scale IQ was 70, verbal IQ 80 and performance IQ was 67. He receives special education at school. He has nasal speech due to velopharyngeal insufficiency.
A clinical suspicion of epilepsy could not be confirmed with EEGs. A brain MRI showed diminished white matter ( Figure S1 ). Prior genetic testing included: chromosome microarray (Affymetrix), which revealed a maternally inherited 0.58 Mb 8p23.3p23.2 microduplication, considered to be a familial variant. Sequencing of the COL2A1 gene was normal.
The family history was non-contributory. Maternal height is 180 cm and paternal height 195 cm. OFC in the mother is 53 cm (11 th percentile), in the father 58 cm (60 th percentile).
On examination at the age of 7 10/12 years, height was 141 cm (Z=2.36) and OFC 56 cm (Z=2.4), with mild facial dysmorphisms including hypertelorism, prominent eyes and flat maxillae (Table 1 and Figure 1 M-O).
The ears were mildly low set and posteriorly rotated. He had fetal fingertip pads.
Individual 6: A 31 year old Finnish female had been followed since age 12.8 years due to a suspicion of an unknown syndrome. She was born at 42 weeks' gestation to a 34 year-old G 5 P 5 mother and a 34 year-old father after an uncomplicated pregnancy. Birth weight was 3.0 kg (Z=-0.52), length was 49.6 cm (Z=-0.24) and OFC was 34.5 cm (Z=0.52). She required IV fluids with 10% dextrose due to hypoglycemia in the neonatal period.
A large nevus flammeus was noted on the forehead and another on the neck. Other features included dense hair, overall hypertrichosis, high palate, and pilonidal cyst, long appearing fingers and toes and deep palmar and plantar creases.
She was noted to have developmental delays early in infancy. At 7.8 years she was diagnosed as having moderate intellectual disabilities and was in special education classes through school. At 15.9 years her developmental age was 5.9 years and at 19 years it was 6.5 years. Dysmorphic features are described and illustrated in Table 1 and Figure Abnormality of head or neck, the abdomen, the eye, the integument, the musculature, the nervous system, the respiratory system, and the skeletal system 
